Purchase Order 75N92E24P00039
Award Date
12/5/23
Potential Completion Date
2/4/24
Potential Value
$23K
Federal Agency
National Human Genome Research Institute
Awardee
Illumina, Inc.
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Rockville, MD 20852, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Service Contract Act
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This contract was awarded by the Department of Health and Human Services' National Institutes of Health's National Human Genome Research Institute to Illumina, Inc., a for-profit manufacturer of sequencing and genomic analysis instruments and reagents. The $122,145.01 firm fixed price delivery order contract was awarded on September 15, 2017 with a completion date of December 15, 2017. It did not have a set-aside designation. Illumina has previously provided a range of genomic sequencing...
The Department of Health and Human Services, National Institutes of Health, National Human Genome Research Institute awarded a firm fixed price delivery order contract to Illumina, Inc., a for-profit manufacturer of gene sequencing systems and reagents. The $105,412.33 contract is for the provision of Illumina's sequencing instruments, consumables, and maintenance services to support genomic analysis and research at the agency. This award does not have any set-aside designation. Illumina has a...
The Department of Health and Human Services, National Institutes of Health, National Human Genome Research Institute awarded a $166,857.69 firm fixed price purchase order contract to Illumina, Inc. for an Illumina Silver Support Plan Service Contract. Illumina is a for-profit manufacturer of genomic sequencing and analysis instruments and reagents. This contract does not have a set-aside designation. The contract is for the provision of sequencing system maintenance and support services to be...
This is a firm fixed price delivery order awarded by the National Institutes of Health (NIH) National Human Genome Research Institute to Illumina, Inc., a for-profit manufacturer of genomic sequencing and analysis products. The $147,003.32 award provides Illumina goods and services including sequencing systems, reagents, and related support for genomic research and diagnostics purposes. Illumina has a history of prime federal contract awards across agencies like NIH, CDC, USDA, and VA, supplying...
The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Human Genome Research Institute awarded Illumina, Inc., a for-profit manufacturer of genetic sequencing systems and analytics, a firm fixed-price purchase order contract worth $803,760.00 for a NovaSeq 6000 sequencing system. The contract was awarded on December 7, 2017 with a completion date of December 31, 2020. Illumina has previously provided a range of sequencing instruments, reagents, and...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a firm-fixed-price purchase order to Illumina, Inc. for a NEXTSEQ 2000 SILVER SUPPORT PLAN. The potential value of the contract is $48,209.00, with a completion date of April 2, 2025. This contract is not set aside and is for the provision of sequencing and array-based solutions to support genomic analysis and life science research. Illumina, a for-profit...
The Department of Health and Human Services National Institutes of Health National Human Genome Research Institute awarded a firm fixed price delivery order to Illumina, Inc., a for-profit manufacturer of genetic sequencing instruments and reagents. The $149,987.33 contract is for the provision of Illumina's NextSeq, NovaSeq, MiSeq, and iSeq sequencing systems, along with related consumables, support, and maintenance services. This award does not have a small business set-aside designation....
This is a firm fixed price purchase order awarded by the National Human Genome Research Institute, a civilian agency, to Illumina, Inc., a manufacturer of sequencing and genomic analysis instruments and reagents. The contract, valued at $159,964.64, is for a Comprehensive Service Contract to provide Silver Support services. There is no set-aside designation for this award. Based on Illumina's prior work with federal agencies like the NIH, CDC, USDA, and VA, the services provided under this...
The Department of Health and Human Services, National Institutes of Health, National Human Genome Research Institute awarded a $142,363.11 firm fixed price delivery order contract to Illumina, Inc., a for-profit manufacturer of genomic sequencing and analysis instruments and reagents. The contract is for the provision of supplies to support research, with no set-aside designation. Illumina has previously received prime federal contracts and subcontracts from various agencies including the NIH,...
The Department of Health and Human Services National Institutes of Health National Human Genome Research Institute awarded a $10,856.27 firm fixed price delivery order to Illumina, Inc. for goods and services to support genomic sequencing and analysis. As the sole manufacturer of the sequencing instruments in use, Illumina will provide reagents, consumables and other supplies under the delivery order citing its proprietary technology. The place of performance is the agency's location in...